Calcimimetic Prescriptions in Fee-for-Service Medicare Beneficiaries Undergoing Dialysis

This cohort study assesses whether calcimimetic prescriptions increased following the Transitional Drug Add-On Payment Adjustment policy among patients subject to high out-of-pocket costs.

from JAMA Health Forum New Online https://ift.tt/u7yKqUF